{
    "clinical_study": {
        "@rank": "78742", 
        "arm_group": {
            "arm_group_label": "Treatment (single incision laparoscopic surgery)", 
            "arm_group_type": "Experimental", 
            "description": "Patients undergo single incision laparoscopic surgery with GelPort\u00ae attachment."
        }, 
        "brief_summary": {
            "textblock": "This study is being done to evaluate single incision laparoscopic surgery (SILS) for\n      colorectal diseases, compared to multi-port laparoscopic surgery. This study is also\n      intended to standardize the SILS technique for colorectal diseases"
        }, 
        "brief_title": "Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Adenomatous Polyp", 
            "Crohn Disease", 
            "Familial Adenomatous Polyposis", 
            "Hereditary Intestinal Polyposis Syndrome", 
            "Recurrent Colon Cancer", 
            "Stage I Colon Cancer", 
            "Stage IIA Colon Cancer", 
            "Stage IIB Colon Cancer", 
            "Stage IIC Colon Cancer", 
            "Stage IIIA Colon Cancer", 
            "Stage IIIB Colon Cancer", 
            "Stage IIIC Colon Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Colonic Neoplasms", 
                "Crohn Disease", 
                "Adenomatous Polyposis Coli", 
                "Adenomatous Polyps", 
                "Intestinal Polyposis"
            ]
        }, 
        "detailed_description": {
            "textblock": "PRIMARY OBJECTIVES:\n\n      I. To report the experience of SILS procedure in the treatment of colorectal disease.\n\n      II. To standardize the SILS technique.\n\n      OUTLINE:\n\n      Patients undergo single incision laparoscopic surgery with GelPort\u00ae attachment.\n\n      After completion of study treatment, patients are followed up at 2 weeks, 3 and 6 months,\n      and at 1 year."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who are willing to give consent and comply with the evaluation and the\n             treatment schedule\n\n          -  Patients with disease processes limited to the right colon; this will include Crohn's\n             disease, polyp disease, and cancers of the right colon\n\n          -  American Society of Anesthesiologists (ASA) =< 3\n\n        Exclusion Criteria:\n\n          -  Inability to obtain informed consent\n\n          -  Previous right colon surgery\n\n          -  Previous extensive abdominal surgery that would limit the laparoscopic approach\n\n          -  Stage IV disease at surgery\n\n          -  Metastatic disease diagnosed by computed tomography (CT), magnetic resonance imaging\n             (MRI), or nuclear imaging\n\n          -  Patient enrolled in other interventional study\n\n          -  ASA score greater than 3\n\n          -  Any condition which precludes compliance with the study (Investigator discretion)\n\n          -  Co-morbid condition(s) that could limit the subject's ability to participate in the\n             study or to comply with follow-up requirements, or that could impact the scientific\n             integrity of the trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 1, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01656746", 
            "org_study_id": "OSU-09123", 
            "secondary_id": "NCI-2012-00604"
        }, 
        "intervention": {
            "arm_group_label": "Treatment (single incision laparoscopic surgery)", 
            "description": "Undergo single incision laparoscopic surgery", 
            "intervention_name": "therapeutic laparoscopic surgery", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Colorectal Disease", 
            "SILS", 
            "colorectal surgery"
        ], 
        "lastchanged_date": "November 4, 2013", 
        "link": {
            "description": "Jamesline", 
            "url": "http://cancer.osu.edu"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43210"
                }, 
                "name": "Ohio State University Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Single Incision Laparoscopic Surgery (SILS) for Colorectal Disease - A Novel Approach", 
        "overall_official": {
            "affiliation": "Ohio State University", 
            "last_name": "David Renton, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Summarized using descriptive statistics (i.e. means, standard deviations, 95% confidence intervals for continuous variables, and frequencies for discrete data).", 
                "measure": "Operative time", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year"
            }, 
            {
                "description": "Summarized using descriptive statistics (i.e. means, standard deviations, 95% confidence intervals for continuous variables, and frequencies for discrete data).", 
                "measure": "Length of skin and fascial incisions", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year"
            }, 
            {
                "description": "Summarized using descriptive statistics (i.e. means, standard deviations, 95% confidence intervals for continuous variables, and frequencies for discrete data).", 
                "measure": "Estimated blood loss", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year"
            }, 
            {
                "description": "Summarized using descriptive statistics (i.e. means, standard deviations, 95% confidence intervals for continuous variables, and frequencies for discrete data).", 
                "measure": "Oncologic sample including size of specimen removed, number of lymph nodes (LN) removed, pathological type and staging, lymph node, vessel or perineural invasion, and status of margins", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01656746"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ohio State University Comprehensive Cancer Center", 
            "investigator_full_name": "David Renton", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Linear mixed model will be applied with repeated measures considering the observations from the same patient are correlated.", 
                "measure": "Quality of life measured using the short form (SF)-12 health related quality of life scale (HQRL) scored using quality metric licensed software", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "Linear mixed model will be applied with repeated measures considering the observations from the same patient are correlated.", 
                "measure": "Quality of life measured using the SF-12 HQRL scored using quality metric licensed software", 
                "safety_issue": "No", 
                "time_frame": "2 weeks"
            }, 
            {
                "description": "Linear mixed model will be applied with repeated measures considering the observations from the same patient are correlated.", 
                "measure": "Quality of life measured using the SF-12 HQRL scored using quality metric licensed software", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Linear mixed model will be applied with repeated measures considering the observations from the same patient are correlated.", 
                "measure": "Quality of life measured using the SF-12 HQRL scored using quality metric licensed software", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Linear mixed model will be applied with repeated measures considering the observations from the same patient are correlated.", 
                "measure": "Visual analogue pain scale scored on the scale from 0 to 10 where 0 is no pain, and 10 is the maximum pain", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "Linear mixed model will be applied with repeated measures considering the observations from the same patient are correlated.", 
                "measure": "Visual analogue pain scale scored on the scale from 0 to 10 where 0 is no pain, and 10 is the maximum pain", 
                "safety_issue": "No", 
                "time_frame": "2 weeks"
            }, 
            {
                "description": "Linear mixed model will be applied with repeated measures considering the observations from the same patient are correlated.", 
                "measure": "Visual analogue pain scale scored on the scale from 0 to 10 where 0 is no pain, and 10 is the maximum pain", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Linear mixed model will be applied with repeated measures considering the observations from the same patient are correlated.", 
                "measure": "Visual analogue pain scale scored on the scale from 0 to 10 where 0 is no pain, and 10 is the maximum pain", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Linear mixed model will be applied with repeated measures considering the observations from the same patient are correlated.", 
                "measure": "Visual analogue cosmesis scale scored on the scale from 0 to 10 where 0 is \"worst scar\", and 10 is the \"best scar\"", 
                "safety_issue": "No", 
                "time_frame": "2 weeks"
            }, 
            {
                "description": "Linear mixed model will be applied with repeated measures considering the observations from the same patient are correlated.", 
                "measure": "Visual analogue cosmesis scale scored on the scale from 0 to 10 where 0 is \"worst scar\", and 10 is the \"best scar\"", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Linear mixed model will be applied with repeated measures considering the observations from the same patient are correlated.", 
                "measure": "Visual analogue cosmesis scale scored on the scale from 0 to 10 where 0 is \"worst scar\", and 10 is the \"best scar\"", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "Ohio State University Comprehensive Cancer Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ohio State University Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2010", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}